Search for: "LILLY v. WYETH"
Results 61 - 80
of 112
Sorted by Relevance
|
Sort by Date
28 Sep 2010, 3:14 pm
Eli Lilly & Co. [read post]
11 Dec 2009, 5:00 am
Wyeth, Inc., 85 Cal.Rptr.3d 299 (Cal. [read post]
1 Feb 2013, 9:42 am
Wyeth, 872 F. [read post]
18 Apr 2007, 10:06 pm
Eli Lilly & Co., 965 F. [read post]
25 Jan 2011, 10:58 pm
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
8 Oct 2015, 5:00 am
Eli Lilly & Co., 58 F. [read post]
27 Jan 2010, 3:00 am
Aurobindo Pharma Limited (Patentcircle) India/US: Indian pharma sector ‘fares well’ in US disputes (PatLit) India: The woes of the grassroot innovator in the agricultural sector (Spicy IP) South Africa: Biopiracy in Alice – Schwabe Pharamaceuticals wishes to patent method for extracting active ingredient in cough medicine from pelargonium roots (Afro-IP) UK: Okay to split costs where actions are joined, says Court of Appeal: Actavis UK Ltd v Eli Lilly & Co Ltd… [read post]
20 May 2009, 5:18 am
BIO Policy Briefing raises the IP social media question (PatentlyBIOtech) Vietnam: Patentability of medical use claims in Vietnam (RelatIP) Products Actonel (Risedronic) – US: CAFC affirms Procter & Gamble’s Actonel patent validity; nonobviousness of positional isomer: Procter & Gamble v Teva (Patent Docs) (Patently-O) (SmartBrief) (SmartBrief) (GenericsWeb) Alimta (Pemetrexed) – US: Eli Lilly and Princeton University sue… [read post]
21 Jun 2012, 4:30 am
Eli Lilly, 2011 U.S. [read post]
9 Jun 2011, 10:02 am
Eli Lilly & Co., 2009 WL 5216930, at *12 (E.D.N.Y. [read post]
23 Apr 2009, 10:00 pm
(Spicy IP) India: Assessing India’s innovation climate (Biotech Blog) Kenya’s anti-counterfeit legislation, India protest (Afro-IP) Mexico: Pharmaceutical trade marks: the Health Law pitfall for applicants (International Law Office) US: BIO IP Counsels’ Committee: Q Todd Dickinson and E Anthony Figg on patent reform (Patent Docs) US: Amgen VP makes case for longer exclusivity period in follow-on biologics legislation (Patent Docs) Products Cepham –… [read post]
15 Oct 2008, 3:02 pm
The Supreme Court wil shortly hear these arguments in the context of a drug case and FDA preamble that attempts to grant immunity, when Wyeth v. [read post]
7 Aug 2008, 12:49 pm
Wyeth, 2005 WL 3589423 (Pa. [read post]
18 Oct 2007, 10:33 pm
The Texas Supreme Court reversed, Eli Lilly v. [read post]
2 Jul 2009, 5:18 am
Wyeth, 894 A.2d 141, 145, 149-50 (Pa. [read post]
6 Jul 2007, 4:29 am
Wyeth Laboratories, Inc., 533 N.E.2d 748, 755 (Ohio 1988). [read post]
5 Jul 2007, 10:37 am
App. 2000); Wyeth-Ayerst Laboratories Co. v. [read post]
28 Jul 2010, 12:06 am
(Patent Docs) Zometa (Zoledronic acid) – US: Teva and Novartis settle patent dispute over Zometa (Patent Docs) Zyprexa (Olanzapine) – Canada: Patent Act contains no reference to invalid selection patents: Eli Lilly v Novopharm (Patent Baristas) [read post]
15 Nov 2013, 11:34 am
Eli Lilly & Co. v. [read post]
13 May 2010, 4:58 pm
(Patent Docs) Evista (Raloxifene) – US: Patent infringement complaint following a Paragraph IV certification: Eli Lilly & Company v. [read post]
